• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

18F-FDG PET/CT 定量参数作为局部不可切除肺癌的预后因素。

F-FDG PET/CT quantitative parameters as prognostic factor in localized and inoperable lung cancer.

机构信息

Servicio de Medicina Nuclear, Complejo Hospitalario Universitario de Badajoz, Badajoz, España.

Servicio de Oncología Radioterápica, Complejo Hospitalario Universitario de Badajoz, Badajoz, España.

出版信息

Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020 Nov-Dec;39(6):353-359. doi: 10.1016/j.remn.2020.05.008. Epub 2020 Jun 27.

DOI:10.1016/j.remn.2020.05.008
PMID:32605894
Abstract

AIM

To assess the utility of F-FDG PET/CT quantitative parameters as prognostic factor in patients diagnosed with localized and inoperable lung cancer treated by stereotactic body radiotherapy (SBRT).

MATERIAL AND METHODS

Fifty patients (42 men) diagnosed in the last 7years with early-stage lung cancer and treated with SBRT alone were assessed by a prospective study. After PET/CT study, metabolic parameters maximum SUV (SUVmax), metabolic tumor volume (MTV) and total lesion glycolysis (TLG) were determined at different thresholds. The prognostic factors for overall survival (OS), cause-specific survival (CS) and disease-free survival (DFS) were analysed by Cox proportional hazards model and the survival analysis by Kaplan-Meier method.

RESULTS

The average follow-up was 39.6months, with 21 recurrences and 24 dead. Univariate analysis determined MTV and MTV as predictors for OS; MTV, MTV, TLG and TLG for CS, and MTV, MTV, MTV, TLG, TLG and TLG for DFS. Survival analysis found statistically significant differences for CS and DFS depending on tumor size and for DFS considering the cut-off values of MTV and TLG (threshold SUVmax=2). SUVmax, age and sex were not shown to be significant factors.

CONCLUSION

Pre-treatment quantitative assessment using metabolic parameters MTV and TLG as well as tumor size proved to be prognostic factors in patients diagnosed with localized and inoperable lung cancer treated by SBRT. Results could help to personalize treatment.

摘要

目的

评估 F-FDG PET/CT 定量参数作为局部不可切除肺癌患者立体定向体部放疗(SBRT)后预后因素的作用。

材料和方法

对过去 7 年中通过 SBRT 单独治疗的 50 名(42 名男性)早期肺癌患者进行前瞻性研究。在进行 PET/CT 研究后,根据不同阈值确定最大标准摄取值(SUVmax)、代谢肿瘤体积(MTV)和总病变糖酵解(TLG)等代谢参数。通过 Cox 比例风险模型分析总生存(OS)、无病生存(DFS)和特异性生存(CS)的预后因素,通过 Kaplan-Meier 方法进行生存分析。

结果

平均随访 39.6 个月,21 例复发,24 例死亡。单因素分析确定 MTV 和 MTV 是 OS 的预测因素;MTV、MTV、TLG 和 TLG 是 CS 的预测因素,而 MTV、MTV、MTV、TLG、TLG 和 TLG 是 DFS 的预测因素。生存分析发现 CS 和 DFS 与肿瘤大小有关,DFS 还与 MTV 和 TLG 的截止值(SUVmax=2)有关,存在统计学差异。SUVmax、年龄和性别均未显示为显著因素。

结论

使用代谢参数 MTV 和 TLG 以及肿瘤大小进行的治疗前定量评估,是局部不可切除肺癌患者接受 SBRT 治疗后的预后因素。结果有助于个性化治疗。

相似文献

1
F-FDG PET/CT quantitative parameters as prognostic factor in localized and inoperable lung cancer.18F-FDG PET/CT 定量参数作为局部不可切除肺癌的预后因素。
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020 Nov-Dec;39(6):353-359. doi: 10.1016/j.remn.2020.05.008. Epub 2020 Jun 27.
2
Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value.采用 FDG PET/CT 测量的容积参数在接受立体定向体部放射治疗的 I 期 NSCLC 患者中的应用:预后价值。
Radiology. 2014 Jan;270(1):275-81. doi: 10.1148/radiol.13130652. Epub 2013 Oct 28.
3
Metabolic tumor volume on FDG-PET/CT is a possible prognostic factor for Stage I lung cancer patients treated with stereotactic body radiation therapy: a retrospective clinical study.18F-氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)上的代谢肿瘤体积是接受立体定向体部放射治疗的I期肺癌患者的一个可能预后因素:一项回顾性临床研究。
J Radiat Res. 2016 Nov;57(6):655-661. doi: 10.1093/jrr/rrw048. Epub 2016 Jul 15.
4
Predictive and prognostic potential of volume-based metabolic variables obtained by a baseline F-FDG PET/CT in breast cancer with neoadjuvant chemotherapy indication.基线F-FDG PET/CT获得的基于体积的代谢变量在有新辅助化疗指征的乳腺癌中的预测和预后潜力。
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2018 Mar-Apr;37(2):73-79. doi: 10.1016/j.remn.2017.09.002. Epub 2017 Nov 2.
5
Metabolic tumor volume derived from F-FDG PET/CT as a prognostic parameter for non-small cell lung cancer (NSCLC) patients.基于 F-FDG PET/CT 的代谢肿瘤体积作为非小细胞肺癌(NSCLC)患者的预后参数。
Hell J Nucl Med. 2022 Jan-Apr;25(1):63-70. doi: 10.1967/s002449912444.
6
Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.(18)F-FDG PET 代谢肿瘤负荷对非小细胞肺癌手术患者的预后价值。
Acad Radiol. 2013 Jan;20(1):32-40. doi: 10.1016/j.acra.2012.07.002. Epub 2012 Sep 19.
7
Prognostic value of preoperative metabolic tumor volumes on PET-CT in predicting disease-free survival of patients with stage I non-small cell lung cancer.术前 PET-CT 代谢肿瘤体积对预测 I 期非小细胞肺癌患者无病生存的预后价值。
Anticancer Res. 2012 Nov;32(11):5087-91.
8
FDG PET/CT texture analysis for predicting the outcome of lung cancer treated by stereotactic body radiation therapy.用于预测立体定向体部放射治疗的肺癌患者预后的氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描纹理分析
Eur J Nucl Med Mol Imaging. 2016 Jul;43(8):1453-60. doi: 10.1007/s00259-016-3314-8. Epub 2016 Jan 30.
9
Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial.局部晚期非小细胞肺癌患者风险分层的 FDG PET/CT 最佳容积学参数:来自 ACRIN 6668/RTOG 0235 试验的结果。
Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):1969-1983. doi: 10.1007/s00259-017-3753-x. Epub 2017 Jul 8.
10
Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer.治疗前 FDG PET/CT 全身总病变糖酵解对非小细胞肺癌的预后价值。
Radiology. 2012 Aug;264(2):559-66. doi: 10.1148/radiol.12111148. Epub 2012 Jun 12.

引用本文的文献

1
Predictive value of 18F-FDG PET/CT metabolic parameters for lymph node metastasis of non-small cell lung cancer.18F-FDG PET/CT代谢参数对非小细胞肺癌淋巴结转移的预测价值
Biomark Med. 2025 Jan;19(2):35-41. doi: 10.1080/17520363.2024.2443379. Epub 2024 Dec 24.
2
Cell-free DNA concentration and fragment size fraction correlate with FDG PET/CT-derived parameters in NSCLC patients.非小细胞肺癌患者的游离 DNA 浓度和片段大小与 FDG PET/CT 衍生参数相关。
Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3631-3642. doi: 10.1007/s00259-021-05306-2. Epub 2021 Apr 2.